stockrowStevanato Group S.p.A.
STVN Healthcare Medical Instruments & Supplies
Stevanato Group S.p.A.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 12.3% from fiscal 2024.
- Revenue
- +5.91%
- EPS
- +17.5%
- Free cash flow
- +4,089.9%
- Total debt
- +2.85%
Quarter to September 2026, against a year earlier
Follow STVN
Alert me
Stevanato Group S.p.A. (STVN) Total debt
Stevanato Group S.p.A.'s total debt at the end of fiscal 2025 was $532.7M, up 13.3% from $470.3M in fiscal 2024. At the end of the quarter to 30 September 2026 it was $545.0M. Over the past ten years it has ranged from $230.9M (fiscal 2022) to $532.7M (fiscal 2025) — the current reading is the highest in ten years. Stevanato Group S.p.A. ranks 16th of 50 Medical Instruments & Supplies companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $532.7M | 13.28% |
| FY2024 | $470.3M | 8.93% |
| FY2023 | $431.7M | 86.98% |
| FY2022 | $230.9M | (21.46%) |
| FY2021 | $294.0M | (31.43%) |
| FY2020 | $428.8M | (0.98%) |
| FY2019 | $433.0M | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $545.0M | 5.05% |
| Jun 2026 | $518.8M | (1.94%) |
| Mar 2026 | $529.1M | (0.68%) |
| Dec 2025 | $532.7M | 0.53% |
| 20 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| TFX Teleflex Incorporated compare | $2.8B |
| NVST Envista Holdings Corporation compare | $1.4B |
| ICUI ICU Medical, Inc. compare | $1.2B |
| MMSI Merit Medical Systems, Inc. compare | $737.4M |
| STVN Stevanato Group S.p.A. | $545.0M |
| WRBY Warby Parker Inc. compare | $170.2M |
| ATRC AtriCure, Inc. compare | $61.0M |
| PLSE Pulse Biosciences, Inc compare | $9.4M |
| MMED MiniMed Group, Inc. compare | — |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on STVN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement